MedTrace Logo

Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial

NCT01070069 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2022-06-07

Study results available
· View outcomes & findings →

Summary

To determine the safety and effectiveness of PEVAR.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

PEVAR (ProGlide closure)

Percutaneous EVAR facilitated by the ProGlide closure device

DEVICE

SEVAR (IntuiTrak)

Standard vascular exposure for access prior to EVAR

DEVICE

PEVAR (Prostar XL closure)

Percutaneous EVAR facilitated by the Prostar XL closure device

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Endologix

    lead INDUSTRY

Principal Investigators

  • Edward B Diethrich, MD · Endologix

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-13
Primary Completion
2012-03-09
Completion
2012-09-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01070069 on ClinicalTrials.gov